 |
Davide Ruggero, PhD
Biographical Sketch
| BS, 1994, Biology, University of Rome
La Sapienza, Italy |
| PhD, 1998, Molecular and Cellular Biology,
University of Rome La Sapienza, Italy |
| |
|
| 1998-2001 |
Post Doctoral Fellow, Memorial Sloan Kettering Cancer
Center, New York |
| 2001-2003 |
Research Associate, Memorial Sloan Kettering Cancer
Center, New York |
| 2004-2007 |
Associate Member (Assistant Professor equivalent),
Human Genetics, Fox Chase Cancer Center, Philadelphia,
PA
|
| 2007-Present |
Assistant Professor, Department of Urology, University
of California, San Francisco |
Davide Ruggero, PhD joined UCSF in July 2007
from the Fox Chase Cancer Center in Philadelphia where he was
an Assistant Professor in the Department of
Human Genetics. Ruggero completed five years of post-doctoral
training in molecular oncology and cancer genetics in the laboratory
of Pier Paolo Pandolfi, MD, PhD at Memorial Sloan-Kettering Cancer
Center in New York. Ruggero's undergraduate education
and early training were completed at the University of Rome in
Italy where he earned a BS cum
laude in Biology
in 1994 and a PhD in Molecular
and Cellular Biology in 1998.
Ruggero has received noteworthy funding to support his groundbreaking
cancer research. In
1994, as a graduate student, he
received an Enichem Society fellowship. While initiating
his post-doctoral research he was awarded an American-Italian
Cancer Foundation fellowship. As a senior post-doctoral fellow
Ruggero was one of two candidates, out of more than four hundred,
to receive Memorial
Sloan-Kettering Cancer Center's Outstanding
Research Fellow Award. In 2005 Ruggero received the prestigious
V-Scholar Foundation's Award for Cancer
Research for his work
on deregulations in protein synthesis during lymphomagenesis. The
V-Scholar Foundation annually
provides grant support to eighteen of the nation's most brilliant
young researchers. Most recently, Ruggero received the 2008 Gertrude
B. Elion Cancer Research Award from the American Association
for Cancer Research that acknowledges the outstanding achievements
of one junior faculty in the country toward cancer research.
Ruggero’s
current research seeks to understand the molecular mechanisms
by which impairments in mRNA translation, cell growth and overall
protein synthesis rates lead to human disease and cancer. The
implications of his research results will be applied to
design a new generation of cancer therapeutic agents that modulate
the cellular proteome at a post-genomic level.
return
to top
|
|
|
|
|
|
